Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Kedar, B"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 7, Iss 12, Pp 2694-2696 (2013)
Background: The Schizophrenia patients are at higher risk for cardiovascular morbidity and mortality. The aim of this casecontrol study is to measure Cardiovascular Disease (CVD) risk parameters in patient group and compare it with normal populati
Externí odkaz:
https://doaj.org/article/8234f33a0a8945839ffc0f5ef8936444
Autor:
Anup N. Nillawar, Kedar B. Joshi, Sandip Bharat Patil, Jayshree S. Bardapurkar, Suhas J. Bardapurkar
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 7, Iss 5, Pp 801-803 (2013)
Introduction: COPD is a major public health problem. More than 50 % of the patients of COPD die because of some cardiovascular event. Traditionally, the risk of CVD is assessed by the presence of dyslipidaemia. Recently, HS-CRP has emerged as a no
Externí odkaz:
https://doaj.org/article/f1e2d2f65a86468592e44dc54c5758cd
Autor:
Sneha B Bansode, Asis K Jana, Kedar B Batkulwar, Shrikant D Warkad, Rakesh S Joshi, Neelanjana Sengupta, Mahesh J Kulkarni
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105196 (2014)
Alzheimer's disease (AD) is a complex neurodegenerative disorder involving multiple cellular and molecular processes. The discovery of drug molecules capable of targeting multiple factors involved in AD pathogenesis would greatly facilitate in improv
Externí odkaz:
https://doaj.org/article/43e4b6efa6564a54a978d1da8f11c73a
Autor:
Anil Kumar Emadabathuni, Siva Subrahmanyam Mendu, Sarath Babu Kaki, Rakesh Sharma, Kedar B. Jivrakh
Publikováno v:
Energy Storage. 2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jagadeeshaprasad, Mashanipalya G.1,2, Batkulwar, Kedar B.1,2, Meshram, Nishita N.3, Tiwari, Shalbha3, Korwar, Arvind M.1, Unnikrishnan, Ambika G.3, Kulkarni, Mahesh J.1,2 mj.kulkarni@ncl.res.in
Publikováno v:
Clinical Proteomics. 3/29/2016, Vol. 13, p1-11. 11p.
Publikováno v:
Thermal Science and Engineering Progress. 20:100752
In this work, the composite adsorbent bed of CaCl2 + Expanded Natural Graphite (80:20) is tested for heat and mass transfer behavior of ammonia adsorption/desorption for thermal energy storage application. 500 g of CaCl2 + ENG was used in the reactor
Autor:
Neelanjana Sengupta, Puneet Khandelwal, Mahesh J. Kulkarni, Kedar B. Batkulwar, Rashmi K. Godbole, Asis K. Jana
Publikováno v:
RSC Advances. 6:108768-108776
Alzheimer's disease (AD) is a neurodegenerative disorder affecting millions of people worldwide, characterized by senile plaques formed due to deposition of insoluble aggregates of amyloid beta (Aβ) peptide in neuronal synapses of the brain. The syn
Autor:
Rashmi K. Godbole, Mahesh J. Kulkarni, Robert J. Williams, Omar Kassaar, Kedar B. Batkulwar, Reema Banarjee
Publikováno v:
Batkulwar, K, Godbole, R, Banarjee, R, Kassaar, O, Williams, R J & Kulkarni, M 2018, ' Advanced glycation end products modulate amyloidogenic APP processing and Tau phosphorylation: a mechanistic link between glycation and the development of Alzheimer’s disease ', ACS Chemical Neuroscience, vol. 9, no. 5, pp. 988-1000 . https://doi.org/10.1021/acschemneuro.7b00410
Advanced glycation end products (AGEs) are implicated in the pathology of Alzheimer's disease (AD), as they induce neurodegeneration following interaction with the receptor for AGE (RAGE). This study aimed to establish a mechanistic link between AGE-
Autor:
Asis K. Jana, Mahesh J. Kulkarni, Neelanjana Sengupta, Kedar B. Batkulwar, Shrikant Dashrath Warkad, Sneha B. Bansode
Publikováno v:
RSC Advances. 5:40070-40075
Tolbutamide is a first generation sulfonylurea drug used for the treatment of type II diabetes. In the present study, the effect of tolbutamide on albumin conformation was investigated using BSA as a model protein. The binding of tolbutamide induced